|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 558.88 USD | +3.50% |
|
+6.67% | +23.28% |
| 10-30 | UK Healthcare Regulator OKs Vertex Pharmaceuticals' Casgevy Gene Therapy for Children From Age Five | MT |
| 10-30 | Vertex Pharmaceuticals Says UK Approves Casgevy for Children Aged 5 and Older | MT |
8846dce5c36789feb57d4bcdf8bd6d51.v4CvE90bly5ngRzuvNslDWI6h9I4FPLF5_YQHmJ6b8A.-7bNPpJO_EQswyuJjIRMaFdxyL8McpeLopVTSTA5K47orecgqDbtWA7Mdw~c52d45e51dd6cb67d877a109a8acdf77
Select your edition
All financial news and data tailored to specific country editions
